4//SEC Filing
TETRAGENEX PHARMACEUTICALS, INC. 4
Accession 0000930413-07-006308
CIK 0001362659operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:11 PM ET
Size
5.7 KB
Accession
0000930413-07-006308
Insider Transaction Report
Form 4
SCHACKER MARTIN F
DirectorCo-CEO/ Chairman of the Board
Transactions
- Award
Option
2007-07-26+850,000→ 2,562,000 totalExercise: $1.00→ Common Stock (850,000 underlying)
Footnotes (2)
- [F1]These options are exercisable on 7/26/07.
- [F2]These options expire on 7/26/17.
Documents
Issuer
TETRAGENEX PHARMACEUTICALS, INC.
CIK 0001362659
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001362659
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:11 PM ET
- Size
- 5.7 KB